Spero Therapeutics (2HA.F) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.49
-0.34
-0.18
-0.03

Details

Expected EPS
-0.32539399999999996
Actual EPS
-0.025688999999999997
Surprise EPS
0.3
Surprise Percent
+92.11%

Description

Spero Therapeutics (2HA.F) has reported earnings of -0.025688999999999997 per share for Q3 2025.

0 Comments

Share your thoughts